Cargando…
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
BACKGROUND: Disentangling nonadherence (NA), drug-drug interactions (DDIs), and disease progression from each other is an important clinical challenge for providers caring for patients with cardiometabolic diseases. NAs and DDIs are both ubiquitous and often overlooked. We studied a novel chronic di...
Autores principales: | Peabody, John W, Ganesan, Divya, Valdenor, Czarlota, Paculdo, David, Schrecker, Joshua, Westerfield, Christopher, Heltsley, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105436/ https://www.ncbi.nlm.nih.gov/pubmed/37061690 http://dx.doi.org/10.1186/s12875-023-02042-4 |
Ejemplares similares
-
Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug–Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary Care Physicians
por: Valdenor, Czarlota, et al.
Publicado: (2022) -
Clinical Utility of Definitive Drug–Drug Interaction Testing in Primary Care
por: Peabody, John, et al.
Publicado: (2018) -
Establishing Clinical Utility for Diagnostic Tests Using a Randomized Controlled, Virtual Patient Trial Design
por: Peabody, John, et al.
Publicado: (2019) -
Variation in Assessing Renal Allograft Rejection: A National Assessment of Nephrology Practice
por: Peabody, John, et al.
Publicado: (2019) -
Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial
por: Burgon, Trever, et al.
Publicado: (2021)